Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: The rationale and design of the Body Size in Stroke Study (BoSSS)

Journal of Cachexia, Sarcopenia and Muscle

Volumn 4, Issue 3, 2013, Pages 199-207

  Knops, Michael ^a   Werner, Claudia G ^a   Scherbakov, Nadja ^a   Fiebach, Jochen ^a   Dreier, Jens P ^a   Meisel, Andreas ^a   Heuschmann, Peter U ^a   Jungehülsing, Gerd J ^a   von Haehling, Stephan ^a   Dirnagl, Ulrich ^a   Anker, Stefan D ^b   Doehner, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Body composition; Ischemic stroke patients; Metabolic profile; Sarcopenia; Skeletal muscle; Skeletal muscle functional capacity; Wasting

Indexed keywords

ADIPONECTIN; ADRENOMEDULLIN; BRAIN NATRIURETIC PEPTIDE; COPEPTIN; ENDOTHELIN; GHRELIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; BRAIN ISCHEMIA; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART FAILURE; HEART OUTPUT MEASUREMENT; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE METABOLISM; MUSCULOSKELETAL FUNCTION; NEUROLOGIC EXAMINATION; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKELETAL MUSCLE; STROKE PATIENT; STUDY DESIGN;

EID: 84884579728     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-013-0103-0     Document Type: Article

References (49)

1. Mackay J, Mensah GA. The atlas of heart disease and stroke. New York: World Health Organization; 2007.
2. Heuschmann PU, Busse O, Wagner M, Endres M, Villringer A, Röther J, et al. Frequency and care of stroke in Germany. Akt Neurol. 2010;37: 333-40.
3. English C, McLennan H, Thoirs K, Coates A, Bernhardt J. Loss of skeletal muscle mass after stroke: a systematic review. Int J Stroke. 2010;5: 395-402.
4. FOOD Trial Collaboration. Poor nutritional status on admission predicts poor outcomes after stroke. Stroke. 2003;34: 1450-6.
5. Ivey FM, Ryan AS, Hafer-Macko CE, Garrity BM, Sorkin JD, Goldberg AP, et al. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke. Cerebrovasc Dis. 2006;22: 368-71.
6. Vermeer SE, Sandee W, Algra A, Koudstaal PJ, Kappelle LJ, Dippel DW. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke. 2006;37: 1413-7.
7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39: 412-23.
8. Scherbakov N, Dirnagl U, Doehner W. Body weight after stroke: lessons from the obesity paradox. Stroke. 2011;42: 3646-50.
9. Scherbakov N, Doehner W. Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. J Cachexia Sarcopenia Muscle. 2011;2: 5-8.
10. Ivey FM, Hafer-Macko CE, Macko RF. Exercise training for cardiometabolic adaptation after stroke. J Cardiopulm Rehabil Prev. 2008;28: 2-11.
11. Ryan A, Dobrovolny C, Silver K, Smith G, Macko R. Cardiovascular fitness after stroke: role of muscle mass and gait deficit severity. J Stroke Cerebrovasc Dis. 2000;9: 185-91.
12. European Stroke Organisation (ESO) Executive Committee, SO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25: 457-507.
13. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42: 227-76.
14. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37: 577-617.
15. Curioni C, André C, Veras R. Weight reduction for primary prevention of stroke in adults with overweight or obesity. Cochrane Database Syst Rev. 2006;4: CD006062.
16. Olsen TS, Dehlendorff C, Petersen HG, Andersen KK. Body mass index and poststroke mortality. Neuroepidemiology. 2008;30: 93-100.
17. Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J. 2013;34: 268-77.
18. Jönsson AC, Lindgren I, Norrving B, Lindgren A. Weight loss after stroke: a population-based study from the Lund Stroke Register. Stroke. 2008;39: 918-23.
19. English C, Thoirs K, Coates A, Ryan A, Bernhardt J. Changes in fat mass in stroke survivors: a systematic review. Int J Stroke. 2012;7: 491-8.
20. Anker SD, Coats AJ. Cardiac cachexia. A syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999;115: 836-47.
21. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160: 1856-61.
22. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81: 543-54.
23. Barber PA, Demchuk AM, Zhang J, Buchhan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Program Early CT Score. Lancet. 2000;355: 1670-4.
24. Norman K, Pirlich M, Sorensen J, Christensen P, Kemps M, Schütz T, et al. Bioimpedance vector analysis as a measure of muscle function. Clin Nutr. 2009;28: 78-82.
25. Doehner W, Anker SD, Godsland IF. Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure. Horm Metab Res. 2005;37: 106-10.
26. Szabo T, von Haehling S, Habedank D, Rauchhaus M, Lainscak M, Sandek A, et al. Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure. Int J Cardiol. 2011;147: 47-51.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28: 412-9.
28. Von Haehling S, Bode-Böger SM, Martens-Lobenhoffer J, Rauchhaus M, Schefold JC, Genth-Zotz S, et al. Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol. Clin Pharmacol Ther. 2010;88: 506-12.
29. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117: 2467-74.
30. Scherbakov N, Sandek A, Martens-Lobenhoffer J, Kung T, Turhan G, Liman T, et al. Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke. Cerebrovasc Dis. 2011;33: 37-46.
31. Sokolski M, Rydlewska A, Krakowiak B, Biegus J, Zymlinski R, Banasiak W, et al. Comparison of invasive and non-invasive measurements of haemodynamic parameters in patients with advanced heart failure. J Cardiovasc Med. 2011;12: 773-8.
32. Von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1: 129-33.
33. Boschmann M, Engeli S, Adams F, Gorzelniak K, Franke G, Klaua S, et al. Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension. 2005;46: 130-6.
34. Gariballa SE, Parker SG, Taub N, Castleden M. Nutritional status of hospitalized acute stroke patients. Br J Nutr. 1998;79: 481-7.
35. Yoo SH, Kim JS, Kwon SU, Yun SC, Koh JY, Kang DW. Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients. Arch Neurol. 2008;65: 39-43.
36. Carin-Levy G, Greig C, Young A, Lewis S, Hannan J, Mead G. Longitudinal changes in muscle strength and mass after acute stroke. Cerebrovasc Dis. 2006;21: 201-7.
37. Jørgensen L, Jacobsen BK. Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study. Bone. 2001;28: 655-9.
38. Stadler K. Peroxynitrite-driven mechanisms in diabetes and insulin resistance-the latest advances. Curr Med Chem. 2011;18: 280-90.
39. Mitchell AJ. Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: a critical literature review. J Stroke Cerebrovasc Dis. 1997;6: 377-88.
40. Fassbender K, Schmidt R, Mössner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage and clinical outcome. Stroke. 1994;25: 1105-8.
41. Allport LE, Butcher KS, Baird TA, MacGregor L, Desmond PM, Tress BM. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke. 2004;35: 1886-91.
42. Christensen H, Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol. 2002;9: 297-301.
43. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest. 2007;117: 289-96.
44. Bassi A, Colivicchi F, Santini M, Caltagirone C. Cardiac autonomic dysfunction and functional outcome after ischaemic stroke. Eur J Neurol. 2007;14: 917-22.
45. Hafer-Macko CE, Yu S, Ryan AS, Ivey FM, Macko RF. Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke. 2005;36: 2021-3.
46. Ajmo Jr CT, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009;218: 47-55.
47. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;20: 1197-204.
48. Hafer-Macko CE, Ryan AS, Ivey FM, Macko RF. Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies. J Rehabil Res Dev. 2008;45: 261-72.
49. Lu LF, Yang SS, Wang CP, Hung WC, Yu TH, Chiu CA, et al. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke. J Stroke Cerebrovasc Dis. 2009;18: 354-9.